J Breast Cancer.  2020 Dec;23(6):588-598. 10.4048/jbc.2020.23.e65.

Application of Biomarkers for the Prediction and Diagnosis of Bone Metastasis in Breast Cancer

  • 1Department of Cancer Center, The First Hospital of Jilin University, Changchun, China
  • 2Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, China


The most common metastatic site of breast cancer is the bone. Metastatic bone disease can alter the integrity of the bone and cause serious complications, thereby greatly reducing health-related quality of life and leading to high medical costs. Although diagnostic methods and treatments for bone metastases (BM) are improving, some patients with early breast cancer who are at high risk of BM are not diagnosed early enough, leading to delayed intervention. Moreover, whole-body scintigraphy cannot easily distinguish BM from nonmalignant bone diseases. To circumvent these issues, specific gene and protein biomarkers are being investigated for their potential to predict, diagnose, and evaluate breast cancer prognosis. In this review, we summarized the current biomarkers associated with BM in breast cancer and their role in clinical applications to assist in the diagnosis and treatment of BM in the future.


Biomarkers; Bone neoplasms; Breast neoplasms; Prognosis
Full Text Links
  • JBC
export Copy
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error